|
Re: What we know and what we don't.....
|
3
|
Resverlogix Corp.
|
May 16, 2019 11:06PM
|
|
Re: PAH Plans get a write up in Pulmonary Hypertension News
|
8
|
Resverlogix Corp.
|
May 21, 2019 01:15PM
|
|
Re: Reata, Bardoxolone, NRF2, CKD, Mitochondria, Inflammation, Redox Balance, Reactive Oxygen Species
|
3
|
Resverlogix Corp.
|
Jun 14, 2019 11:23AM
|
|
Re: Reata, Bardoxolone, NRF2, CKD, Mitochondria, Inflammation, Redox Balance, Reactive Oxygen Species
|
2
|
Resverlogix Corp.
|
Jun 14, 2019 11:30AM
|
|
Re: Could BETonMACE Cognition Sub-Study be presented at AAIC this month?
|
3
|
Resverlogix Corp.
|
Jul 02, 2019 12:50PM
|
|
Re: Could BETonMACE Cognition Sub-Study be presented at AAIC this month?
|
6
|
Resverlogix Corp.
|
Jul 03, 2019 12:19PM
|
|
Re: Sedar filings - Loan balance
|
5
|
Resverlogix Corp.
|
Jul 29, 2019 10:20PM
|
|
Re: ALP Levels Predict Adverse Cardiovascular Outcomes And Cognitive Impairment In High Risk Patients
|
8
|
Resverlogix Corp.
|
Aug 08, 2019 02:15PM
|
|
Re: Shorts
|
3
|
Resverlogix Corp.
|
Aug 15, 2019 02:35PM
|
|
Re: Contest
|
7
|
Resverlogix Corp.
|
Sep 16, 2019 12:35PM
|
|
Re: Contest
|
2
|
Resverlogix Corp.
|
Sep 16, 2019 01:32PM
|
|
Re: Now published: Rationale, design, and baseline characteristics of the BETonMACE trial
|
1
|
Resverlogix Corp.
|
Sep 16, 2019 02:38PM
|
|
Re: Now published: Rationale, design, and baseline characteristics of the BETonMACE trial
|
1
|
Resverlogix Corp.
|
Sep 16, 2019 03:37PM
|
|
Re: Now published: Rationale, design, and baseline characteristics of the BETonMACE trial
|
3
|
Resverlogix Corp.
|
Sep 16, 2019 04:27PM
|
|
Re: BIO CEO Slides Up
|
2
|
Resverlogix Corp.
|
Sep 18, 2019 07:00PM
|
|
Re: EagleEyeCap...
|
9
|
Resverlogix Corp.
|
Oct 02, 2019 02:45PM
|
|
Re: The synergy of rosuvastatin (Crestor) with apabetalone
|
7
|
Resverlogix Corp.
|
Oct 03, 2019 12:20PM
|
|
Re: The synergy of rosuvastatin (Crestor) with apabetalone
|
4
|
Resverlogix Corp.
|
Oct 03, 2019 12:33PM
|
|
Re: Apabetalone and Alkaline Phosphatase
|
3
|
Resverlogix Corp.
|
Oct 12, 2019 11:36AM
|
|
Re: I asked IR...
|
9
|
Resverlogix Corp.
|
Oct 24, 2019 05:30PM
|
